The Rhabdoid Tumor Treatment Industry is undergoing a rapid transformation as it enters the 2025–2032 forecast period. Characterized by aggressive, rare pediatric malignancies that typically affect infants and young children, this market is shifting from traditional aggressive multimodal therapies toward precision oncology and AI-driven drug discovery. https://www.databridgemarketresearch.com/reports/global-rhabdoid-tumor-treatment-market